“In conclusion, 2 weeks of therapy with erdosteine reduced the marker for mucus glycoproteins ( fucose ) in patients with chronic bronchitis but did not interfere with the pharmacokinetics of xanthine derivatives.”
“We found that a … week treatment with erdosteine (300 mg 3 times daily) was able to … significantly (p<0.05) the sputum apparent viscosity, fucose content , and macromolecular dry weight (MDW) with no statistically significant influence on sputum elasticity, DNA, albumin, total proteins, total IgA, lactoferrin, and lysozyme content.”